<DOC>
	<DOCNO>NCT00188578</DOCNO>
	<brief_summary>Standard treatment gynecological cancer radiation therapy two phase ; whole pelvic radiation internal radiation boost , also call brachytherapy boost , treat remain tumour . The purpose study test alternative radiation boost treatment call conformal intensity modulate radiation therapy IMRT . Currently , complete information overall effectiveness IMRT compare brachytherapy conformal radiotherapy . We know IMRT allow radiation beam accurately focus tumor , thereby spar normal tissue radiation damage lower risk side effect . We investigate extent IMRT use protect normal tissue patient cervix , uterine vaginal cancer radiation beams much side effect radiation reduce .</brief_summary>
	<brief_title>Intensity Modulated Radiation Therapy - Gyne Cancer ( GY03.2 )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Biopsyproven carcinoma cervix , uterus vagina ; FIGO stage T1B4A , NO/1 , MO , treat definitive radiotherapy without chemotherapy , Biopsyproven pelvic recurrence carcinoma uterus previously untreated biopsyproven vaginal carcinoma treat radically radiotherapy unsuitable brachytherapy boost . Patients suitable intracavitary brachytherapy . ECOG performance status 0 , 1 , 2 Age â‰¥ 18 year Ability give inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>